Abstract:Objective To investigate the expression of cytokines including IL-2,IL-4,IL-17 and IL-10 in the mucosa of patients with ulcerative colitis(UC),in order to determine the correlation between the expression levels of these cytokines and disease activity. Methods Thirty-six cases of UC were enrolled in this study.The disease activity was scored by Sutherland DAI in UC patients.Endoscopic mucosa biopsy was performed when UC patients took colonoscopy examination.The expression levels of cytokines including IL-2,IL-4,IL-17 and IL-10 in the intestinal mucosa were assessed by semiquantitative PCR.In 10 cases,these cytokines were measured by immunohisochemistry,and peripheral blood erythrocyte sedimentation rate(ESR) and c-reactive protein(CRP) were measured simultaneously. Results The expression level of IL-2 was significantly higher in inflamed mucosa than in normal mucosa,but there was no evident difference in protein expression of IL-2 among subgroups of UC patients classified by disease activity.However,the mRNA expression of IL-2 was higher in mild group than in moderate and severe.The expression level of IL-4 was higher in inflamed mucosa than in normal mucosa.Among subgroups of UC patients,the expression level of IL-4 was higher in severe than in mild and moderate.The expression level of IL-17 was higher in inflamed mucosa than in normal mucosa.Among subgroups of UC patients,the expression level of IL-17 was higher in severe than in mild and moderate.The protein and mRNA expression levels of IL-10 were higher in inflamed mucosa than in normal mucosa,but no statistical significance in the former.Among subgroups of UC patients,the expression level of IL-10 was higher in mild than in moderate and severe.No correlation was seen between the expression levels of those cytokines and ESR or CRP level. Conclusions Cytokines like IL-2、IL-4、IL-17 and IL-10 may be involved in the pathogenesis of UC through pro-or anti-inflammation effect.The mRNA expression levels of these 4 cytokines and protein expression levels of IL-4、IL-17 and IL-10 are correlated with disease activity of UC to some extent,and can be used to evaluate the activity of UC.

Related Research Between Mast Cell and Intestinal Proteinase Activated Receptor-2, NF-kB Expressed in Intestinal Mucosa of Patients with Ulcerative Colitis

Expression of proteinase activated receptor-2 in intestinal mucosa of patients with ulcerative colitis

Expression of Monocyte Chemoatractant Protein 1 in Colonic Mucosa of Patients with Ulcerative Colitis.

Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice

Relationship between mast cells and expressions of interleukin-2 and interferon-γ on colonic mucosa in patients with post-infective irritable bowel syndrome

Expression and significance of PPARγand NFkB p65 in intestinal mucosal tissues of mice with ulcerative colitis

Mast cells and eosinophils are involved in activation of ulcerative colitis.

Expression of MCP-1 and NF-κB in models of ulcerative colitis

Research on Correlation Between Psychological Factors, Mast Cells, and PAR-2 Signal Pathway in Irritable Bowel syndrome

Role and significance of lymphotoxin α1/β2 and its receptor LTβR in intestinal mucosal immunity of ulcerative colitis

Tryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome

The Expression of HBD-2, NF-kB, IL-6 and IL-23 in Colonic Mucosa of Ulcerative Colitis and Irritable Bowel Syndrome

The Expressions of IL-2, IL-4, IL-17 and IL-10 in Ulcerative Colitis (UC) Mucosa and Its Relation with Disease Activity

Effects of Mast Cells Induced by NSAIDs Impair Intestinal Epithelial Barrier Function In Vivo and In Vitro

Upregulated mRNA expression of major histocompatibility complex class I chain-related gene A in colon and activated natural killer cells of Chinese patients with ulcerative colitis

Expressions of cannabinoid receptor in serum and intestinal tissue with ulcerative colitis

Changes of Substance P, Vasoactive Intestinal Peptide and Mast Cell in Colonic Mucosa of Patients with Irritable Bowel Syndrome

Expression of cannabinoid receptor in intestinal tissue in patients with ulcerative colitis

The role of protease activated receptor 2 in visceral sensitivity of irritable bowel syndrome patients

Molecular Activity of Inflammation and Epithelial-Mesenchymal Transition in the Microenvironment of Ulcerative Colitis

[The Changes of Mucosal Mast Cells and Substance P in Patients with Irritable Bowel Syndrome].